the future, although the minmum contract data set should assist in this. The current trends to shorten lengths of stay and increase day case and out-patient treatment could adversely affect registration and case ascertainment, especially if fewer people die in hospital.
Routine statistics on national cancer incidence and survival are derived by the Office of Population Censuses and Surveys (OPCS) from the 12 cancer registries of England and Wales (OPCS and Cancer Research Campaign, 1981; OPCS, 1993) .
They are used to monitor national trends in cancer incidence and survival and as a baseline for epidemiological studies and health services research (Swerdlow, 1986) . In a recent study we showed that the quality and reliability of registrations are affected by the proportion of death certificate only registrations (DCOs) held by the registry (Pollock and Vickers, 1994) . DCOs are registrations based on death certificate information alone (Jensen et al., 1991) .
Although OPCS holds no national data on DCOs, the annual reports of the Thames Cancer Registry (TCR) indicate that, between 1987 and 1989, DCOs constituted 23.8% of all registrations (Thames Cancer Registry, 1992) . Since 1983, a rapid increase has taken place in Thames DCO rates. The registry has explained this rise by reference to the decision taken in 1983 (for financial reasons) not to follow up patients dying at home (Thames Cancer Registry, 1992 Nimety-nine per cent confidnce intervals were alculated using the method described by Gardner and Altman (1989) . The signii of variations was further measured using the chi-square test for heterogenety described by Breslow and Day (1987) . Each district DCO ratio was ranked and assigned to quartiles such that quartile 1 contained the 14 districts with the lowest DCO ratios and quartile 4 comprised the 14 districts with the highest DCO ratios.
It might be expected that higher proportions of DCOs will be found in districts with a higher incidence of poor survival cancers, e.g. lung cancer. To adjust for district differences in the ratio of high survival to low survival cancers 2 year relative survival rates were calculated for the 15 most common primary tumour sites in each sex for all registrations excluding DCOs (n = 104 370), using the Hakuinen computer program (Hakulinen et al., 1988) . Each case, including DCOs (n = 134 927), was then assigned a survival coefficient corresponding to the relative survival rate assocated with the primary tumour site. Relative survival is the ratio of the survival observed in a group of cancer patients to the survival expected if they were only subject to the general (allcause) mortality in a standard population. The standard population used in this study was the England and Wales population.
To test the significnce of the association between district of residence and DCO registration while controlling for age at diagnosis, tumour survival and patient sex, a (backwards stepwise) multiple logistic regression model was generated.
The model used DHA quartiles rather than DHAs (to minimise the number of dummy variables needed). Since our measurement of survival is a proxy for tumour site ( Figure 1 shows the distribution of standardised ratios for DCO registations (adjusted for age and sex) for each DHA, with 99% confidence intervals. The chisquare test for heterogeneity showed signint variations in district ratios (X2 for heterogeneity = 1371.4, P<0.0001).
Place of death The distribution of deaths and DCO registrations by place of death and quartie of residence is shown in on deceased patients only (adding place of death). In both cohorts, all variables -DHA quartile, survival time, age, sex and (in the deceased patients' cohort) place of death -were strongly associated with DCO registration (P<O.001).
Significant interactions were found in both cohorts between patient sex and survival and between patient sex and age at diagnosis (P<0.01): females had better survival but tended to be older than males. A further significant negative interaction was found in the deceased patients' cohort between DHA quartile of residence and place of death (P<0.01). Quartile 1, comprising the districts with the lowest DCO registration ratios, had the smallest proportion of cases dying in the NHS and the largest proportion of cases dying at home, while the converse was true in quartile 4. The fit of both models improved when age at diagonsis was supplemented by the squared term (age at diagnosis squared), signifying that the relationship between age at diagnosis and source of registration was non-linear. Table VII shows that, within all quartles, the odds of being registered as a DCO increase for patients dying in the private sector, hospices and at home. Odds also broadly increase by quartile (though odds are frequently higher in DHA quartile 3 than in DHA quartile 4). For patients dying in the private sector, the odds of being registered by DCO (relative to patients registered in DHA quartile 1, dying in the acute sector) were 2.74 in quartile 1, 3.24 in quartile 2, 4.03 in quartile 3 and 2.96 in quartile 4. For patients dying at home the corresponding figures were 2.87, 5.62, 9.27 and 5.97 respectively. stting makes registration more difficult.
After adjustng for age and sex, there are ignificant variations in DCO ratios by district of rinc. However, these do not take account of differences in tumour site and survival. Districts with high rates of poor-survival cancers might be expected to have higher DCO rates, as they would have kss time to regiser cases in life. Inded, the observed variations in district DCO ratios could be a function of interdistrict differences in the burden of disease (Table IV) . However, our multiple logistic regression models indicate that district differences in DCO rates persist, even after adjusting for differences in age, sex and survival time.
Patients residnt in the fourth quartie dying in the acute stor were 3.71 times more likely to be rgistered as DCO cases than their counterparts in the first quartile. In the cohort comprisng deceased patients only, we were able to confirm that the strong association with DHA quartile of dence was independent of place of death. This is consistent with an observation reported in a previous study that the organisation of medical records departments appeared to affect the ability of clerks and researchers to retrieve notes (Vickers and Pollock, 1993) .
However, nearly 41% of all DCO patients die in the acute NHS hospital sector, which suggsts both a failure of ascertainment and a failure of DCO registration procedures in acute NHS hospital settings. More efficient registrations at NHS hospitals could dramatically reduce the proportion of DCOs in Thames.
Dying outside the NHS also increases the odds of being a DCO, so that in quartik 1 elevated odds ratios (relative to patients dying in the acute sector) were also found for patients dying in hospices (OR= 1.35), long-stay treatment centres (OR = 2.89), nursing homes (OR = 2.39) and private institutions (OR = 2.74). These results suggest that changing patterns of care will have serious implications for the ability of regisries to ascertain cases both prospectively and retrospectively. Shorter lengths of stay and more day case and out-patient treatments may make it harder for registry clerks to retriev notes and ascertain cases. It is to be hoped that the introduction of the minimum contract data set for cancer will counteract these developments (NHS ME Executive Letter, EL (92)95). Greater use of the private sector and hospices may also make registration more difficult and timeconsuming for cerks attempting to retneve retrospective information on cases ascertained by death certificte as neither the private sector nor hospic are bound by the minimum contract data set to provide information to the cancer registries.
Conchuion OPCS and cancer registries should collect routine data on DCOs by site, district of residence and place of death. Cancer registration quality assuranc programmes should use these measures to improve the efficency of case ascertainment and ristration programmes and to consider the implications of high rates of DCOs for cancer registration.
